Troglitazone withdrawn from market.
- Published in:
- Patient Care (Print), 2000, v. 34, n. 10, p. 12
- By:
- Publication type:
- Article
Works matching DE "WARNER-Lambert Co."
Results: 27
1
2
REFLECTING On a MEGA-MERGER.
- Published in:
- 2001
- By:
- Publication type:
- Interview
3
Plausibility after Warner-Lambert v Actavis : fantastic legal tests and where to find them.
- Published in:
- Journal of Intellectual Property Law & Practice, 2019, v. 14, n. 7, p. 552, doi. 10.1093/jiplp/jpz051
- By:
- Publication type:
- Article
4
Pain for Pfizer--claims of pregabalin patent deemed insufficient.
- Published in:
- Journal of Intellectual Property Law & Practice, 2016, v. 11, n. 8, p. 569, doi. 10.1093/jiplp/jpw087
- By:
- Publication type:
- Article
5
Interlocutory injunction applications in Australia.
- Published in:
- Journal of Intellectual Property Law & Practice, 2015, v. 10, n. 3, p. 170, doi. 10.1093/jiplp/jpu244
- By:
- Publication type:
- Article
6
Warner-Lambert.
- Published in:
- Business & Society Review (00453609), 1995, n. 95, p. 74
- By:
- Publication type:
- Article
7
In Reply.
- Published in:
- 1989
- By:
- Publication type:
- Letter
8
Industry/Academia Relations: Are the Problems a Barrier to Cooperation?
- Published in:
- Journal of Dental Research, 1988, v. 67, n. 10, p. 1353, doi. 10.1177/00220345880670102301
- By:
- Publication type:
- Article
9
Patently unclear.
- Published in:
- Chemistry & Industry, 2016, v. 80, n. 8, p. 37, doi. 10.1002/cind.808_14.x
- Publication type:
- Article
10
Ian Anderson CBiol MIBiol.
- Published in:
- Biologist, 2009, v. 56, n. 1, p. 51
- Publication type:
- Article
11
Pharmaceutical; trademark; patents; news.
- Published in:
- Journal of Generic Medicines, 2011, v. 8, n. 3, p. 176, doi. 10.1177/1741134311416548
- By:
- Publication type:
- Article
12
Patentwatch: Good-faith explanation.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 10, p. 804, doi. 10.1038/nrd1861
- By:
- Publication type:
- Article
13
Implementing a Distribution-Network Decision-Support System at Pfizer/ Warner-Lambert.
- Published in:
- Interfaces, 2002, v. 32, n. 4, p. 28, doi. 10.1287/inte.32.4.28.54
- By:
- Publication type:
- Article
14
Crackdown on health-care fraud is under way.
- Published in:
- Contemporary Pediatrics, 2003, v. 20, n. 8, p. 11
- Publication type:
- Article
15
5. REGULATION OF UNFAIR COMPETITION.
- Published in:
- Journal of Marketing, 1978, v. 42, n. 4, p. 89
- By:
- Publication type:
- Article
16
REGULATION OF UNFAIR COMPETITION.
- Published in:
- Journal of Marketing, 1978, v. 42, n. 2, p. 116
- By:
- Publication type:
- Article
17
V. REGULATION OF UNFAIR COMPETITION.
- Published in:
- Journal of Marketing, 1976, v. 40, n. 3, p. 101
- By:
- Publication type:
- Article
18
V. REGULATION OF UNFAIR COMPETITION.
- Published in:
- Journal of Marketing, 1975, v. 39, n. 3, p. 88
- By:
- Publication type:
- Article
19
New Products.
- Published in:
- 1984
- Publication type:
- Product Review
20
Isolation Technology for Research and Development Applications: From Concept to Production.
- Published in:
- Pharmaceutical Development & Technology, 2000, v. 5, n. 4, p. 507, doi. 10.1081/PDT-100102034
- By:
- Publication type:
- Article
21
Expert Testimony: Expert Witnesses Must be Prepared to Produce Positive Evidence to Establish General Causation in Drug Products Liability Actions--Ruggiero v. Warner-Lambert Co.
- Published in:
- American Journal of Law & Medicine, 2005, v. 31, n. 4, p. 529, doi. 10.1017/s0098858800002689
- By:
- Publication type:
- Article
22
THE FTC AND CORRECTIVE ADVERTISING: ACT ONE.
- Published in:
- American Business Law Journal, 1979, v. 17, n. 2, p. 246, doi. 10.1111/j.1744-1714.1979.tb00580.x
- By:
- Publication type:
- Article
23
Research collaborations.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 7, p. 700, doi. 10.1038/77202
- Publication type:
- Article
24
Warner-Lambert acquires speculative Agouron pipeline.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 3, p. 211, doi. 10.1038/6913
- By:
- Publication type:
- Article
25
W-L launches nutraceuticals.
- Published in:
- Nature Biotechnology, 1998, v. 16, n. 11, p. 993, doi. 10.1038/3419
- By:
- Publication type:
- Article
26
RECONSIDERING THE TRADITIONAL ANALYSIS: SHOULD BUCKMAN ALONE SUPPORT PREEMPTION OF FRAUD-ON-THE-FDA EXCEPTIONS TO TORT IMMUNITY?
- Published in:
- New York University Journal of Legislation & Public Policy, 2014, v. 17, n. 4, p. 1055
- By:
- Publication type:
- Article
27
TWO STEPS FORWARD, ONE STEP BACK: CONGRESS HAS CODIFIED THE TEDFORD EXCEPTION, BUT WILL INCONSISTENT APPLICATIONS OF "BAD FAITH" SWALLOW THE RULE?
- Published in:
- Northern Kentucky Law Review, 2013, v. 40, n. 1, p. 233
- By:
- Publication type:
- Article